Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Calcipotriol 50micrograms/g ointment
1305020D0AAAAAA
|
Calcipotriol | Calcipotriol | Skin | 36,104 |
|
E45 Itch Relief cream
1302010U0BJAAAN
|
E45 Itch Relief | Urea | Skin | 35,951 |
|
Oilatum cream
130201000BBJPCD
|
Proprietary compound emollients | Other emollient preparations | Skin | 35,098 |
|
Epiduo 0.1%/2.5% gel
1306010Z0BBAAAA
|
Epiduo | Adapalene and benzoyl peroxide | Skin | 34,572 |
|
Efudix 5% cream
1308010Y0BBAAAA
|
Efudix (Sunscreen) | Fluorouracil (Sunscreen) | Skin | 34,562 |
|
Calcipotriol 50microg/Betamethasone diprop 500microg/g foam
1305020D0AAAIAI
|
Calcipotriol | Calcipotriol | Skin | 33,788 |
|
Aqueous cream
130201100AAAMAM
|
Generic compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 32,834 |
|
Canesten HC cream
1304000V0CHABCI
|
Canesten (hydrocortisone) | Hydrocortisone | Skin | 32,467 |
|
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel
1305020D0AAAGAG
|
Calcipotriol | Calcipotriol | Skin | 31,606 |
|
Sudocrem antiseptic healing cream
1302020E0BGAAAL
|
Sudocrem | Zinc oxide | Skin | 31,250 |
|
Dermol 600 bath emollient
130201100BBAQA0
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 31,235 |
|
Betamethasone dipropionate 0.064% / Clotrimazole 1% cream
1304000D0AACACA
|
Betamethasone esters | Betamethasone esters | Skin | 29,639 |
|
Duac Once Daily gel (5% and 1%)
1306010Y0BBAAAA
|
Duac | Benzoyl peroxide and clindamycin phosphate | Skin | 29,514 |
|
Chlorhexidine gluconate 4% solution
1311020L0AAAIAI
|
Chlorhexidine gluconate (Topical cleanser) | Chlorhexidine gluconate | Skin | 29,029 |
|
Metronidazole 0.75% gel
1310012K0AAARAR
|
Metronidazole (Topical) | Metronidazole | Skin | 29,000 |
|
Lotriderm cream
1304000D0BDABCA
|
Lotriderm | Betamethasone esters | Skin | 28,325 |
|
Benzoyl peroxide 3% / Clindamycin 1% gel
1306010Y0AAABAB
|
Benzoyl peroxide/clindamycin phosphate | Benzoyl peroxide and clindamycin phosphate | Skin | 26,918 |
|
Benzoyl peroxide 5% gel
1306010C0AAABAB
|
Benzoyl peroxide | Benzoyl peroxide | Skin | 26,521 |
|
Aciclovir 5% cream
1310030C0AAAAAA
|
Aciclovir (Topical) | Aciclovir | Skin | 25,378 |
|
Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion
1306010I0AAABAB
|
Erythromycin (Topical) | Erythromycin | Skin | 25,362 |
|
Dovobet ointment
1305020D0BCAAAF
|
Dovobet | Calcipotriol | Skin | 25,155 |
|
Adapalene 0.1% gel
1306010H0AAAAAA
|
Adapalene | Adapalene | Skin | 25,010 |
|
HiBiScrub 4% solution
1311020L0BEAAAI
|
HiBiScrub | Chlorhexidine gluconate | Skin | 24,640 |
|
Clobet 0.05%/Oxytetracycline 3% /Nystatin 100,000units/g crm
1304000H0AACACA
|
Clobetasone butyrate (Topical) | Clobetasone butyrate | Skin | 24,542 |
|
Nizoral 2% shampoo
1309000I0BBAAAA
|
Nizoral (Scalp) | Ketoconazole | Skin | 24,529 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.